首页> 外国专利> aids laekemedel baserade pao hiv proteasinhibitorer.

aids laekemedel baserade pao hiv proteasinhibitorer.

机译:基于HIV蛋白酶抑制剂的艾滋病药物。

摘要

A therapeutic active compound, especially for treating AIDS, comprising (A min )k-(Z)n-(Y)m-A sec wherein A min is CHEM or hydrogen, wherein R1 is OR2, NR3R2 or CR2R3R4, R2,R3 and R4 are, independent of each other, hydrogen, an aliphatic or an aromatic, wherein k is one or zero, wherein when Z is hydrogen, k is zero, Z is hydrogen, Ser or Thr or R1 - @, wherein n is one or zero, with the proviso that when Y is hydrogen, n is zero, Y is hydrogen or R1 - @, or CHEM wherein R9 is hydrogen or an aliphatic or aromatic, wherein m is one or zero, wherein when E4 is hydrogen, m is zero, A sec is CHEM wherein E4 is hydrogen or Asn or R1- @, wherein CHEM is a 4 to 7 membered ring system, wherein only Q, Q min , Q sec may be different from carbon, wherein the substituent is an aliphatic or aromatic, wherein E1 is @; wherein E3 is CHEM wherein E2 is CHEM wherein E4 is hydrogen or Asn, or CHEM but if E2 is R5 CHEM E4 is not R2-O- @- , wherein R5 is an aromatic or aliphatic, wherein X is hydrogen or R1 or CHEM wherein R6 is an aliphatic, wherein R10 is hydrogen or CHEM wherein A2 has the formula CHEM
机译:一种治疗活性化合物,特别是用于治疗艾滋病的活性化合物,其包含(A min)k-(Z)n-(Y)mA sec,其中A min为或氢,其中R 1为OR 2,NR < 3 R 2或CR 2 R 3 R 4,R 2,R 3和R 4彼此独立地为氢,脂族或芳族基,其中k为一或零,其中当Z为氢时,k为零,Z为氢,Ser或Thr或R 1-@,其中n为一或零,条件是当Y为氢时,n为零,Y是氢或R 1-@,或,其中R 9是氢或脂族或芳族基,其中m是一个或零,其中当E 4是氢时,m是零,A sec是,其中E 4是氢或Asn或R 1--,其中是4至7元环系统,其中仅Q,Q min和Q sec可不同于碳,其中取代基为脂族或芳族基,其中E 1为@;其中E 3为其中E 2为其中E 4为氢或Asn,或,但如果E 2为R 5 E 4不是R 2 -O- @-,其中R 5是芳族或脂族基,其中X是氢或R 1或其中R 6是脂族基,其中R 1 <0>是氢或,其中A <2>具有式

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号